CS256366B2 - Method of new 3-(1-piperidinylalkyl)-4h-pyridol(1,2-pyrimidine-4-on derivatives production - Google Patents
Method of new 3-(1-piperidinylalkyl)-4h-pyridol(1,2-pyrimidine-4-on derivatives production Download PDFInfo
- Publication number
- CS256366B2 CS256366B2 CS812134A CS213481A CS256366B2 CS 256366 B2 CS256366 B2 CS 256366B2 CS 812134 A CS812134 A CS 812134A CS 213481 A CS213481 A CS 213481A CS 256366 B2 CS256366 B2 CS 256366B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- parts
- piperidinyl
- methyl
- pyrido
- pyrimidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13484580A | 1980-03-28 | 1980-03-28 | |
US06/191,632 US4342870A (en) | 1980-03-28 | 1980-09-29 | Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CS256366B2 true CS256366B2 (en) | 1988-04-15 |
Family
ID=26832744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS812134A CS256366B2 (en) | 1980-03-28 | 1981-03-24 | Method of new 3-(1-piperidinylalkyl)-4h-pyridol(1,2-pyrimidine-4-on derivatives production |
Country Status (22)
Country | Link |
---|---|
US (1) | US4342870A (fr) |
EP (1) | EP0037265B1 (fr) |
AU (1) | AU537700B2 (fr) |
BG (1) | BG36199A3 (fr) |
CA (1) | CA1163994A (fr) |
CS (1) | CS256366B2 (fr) |
DE (1) | DE3168433D1 (fr) |
DK (1) | DK159390C (fr) |
ES (1) | ES500814A0 (fr) |
FI (1) | FI71737C (fr) |
GR (1) | GR72488B (fr) |
HU (1) | HU187329B (fr) |
IE (1) | IE51319B1 (fr) |
IL (1) | IL62494A (fr) |
MA (1) | MA19107A1 (fr) |
NO (1) | NO156752C (fr) |
NZ (1) | NZ196522A (fr) |
PH (1) | PH16530A (fr) |
PT (1) | PT72740B (fr) |
RO (1) | RO82508A (fr) |
SU (1) | SU1068037A3 (fr) |
YU (1) | YU43010B (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4443451A (en) | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
US4548938A (en) * | 1981-07-15 | 1985-10-22 | Janssen Pharmaceutica N.V. | 5-H-1,3,4-thiadiazolo[3,2-a]pyrimidin-5-one compounds |
US4355037A (en) * | 1981-11-12 | 1982-10-19 | Hoechst-Roussel Pharmaceuticals | 3-(4-Piperidyl)-1,2-benzisoxales |
US4485107A (en) * | 1982-11-01 | 1984-11-27 | Janssen Pharmaceutica N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones |
US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
US4888426A (en) * | 1983-11-30 | 1989-12-19 | Janssen Pharmaceutica N.V. | 1-(5-methyl-furan-2-ylmethyl)-N-(4-piperidinyl)imidazo [4,5-6]pyridine-2-amine |
US4695569A (en) * | 1983-11-30 | 1987-09-22 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines |
PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
US4548939A (en) * | 1984-10-01 | 1985-10-22 | Janssen Pharmaceutica N. V. | 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones |
US4804663A (en) * | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
DE3751974T2 (de) * | 1986-09-22 | 1997-04-10 | Janssen Pharmaceutica Nv | Serotonin-Antagonisten zur Behandlung von Wunden |
IL90879A0 (en) * | 1988-09-02 | 1990-02-09 | Janssen Pharmaceutica Nv | 3-piperidinyl-indazole derivatives,their preparation and antihypertensive compositions containing them |
CA2000786C (fr) * | 1988-11-07 | 1999-01-26 | Cornelus G. M. Janssen | 3-piperidinyl-1,2-benzisoxazoles |
HU207310B (en) * | 1988-12-02 | 1993-03-29 | Pfizer | Process for producing aryl-piperidine derivatives |
WO1990011093A1 (fr) * | 1989-03-23 | 1990-10-04 | Mallinckrodt, Inc. | Compose de piperidine marque a l'iode ou au brome radioactif, son procede de preparation et composition comprenant ledit compose |
DE4138756A1 (de) * | 1991-11-26 | 1993-05-27 | Troponwerke Gmbh & Co Kg | Kombination mit neuroprotektiver wirkung |
US5266571A (en) * | 1992-01-09 | 1993-11-30 | Amer Moh Samir | Treatment of hemorrhoids with 5-HT2 antagonists |
ES2163407T3 (es) * | 1992-02-13 | 2002-02-01 | Merrell Pharma Inc | Derivados piperidinilos tiaciclicos. |
WO1994001437A1 (fr) | 1992-07-13 | 1994-01-20 | Janssen Pharmaceutica N.V. | Nouveaux derives de 4-(3-benzofuranyl) piperidinyle et 4-(3-benzothienyle) piperidinyle et compositions pharmaceutiques les contenant |
RO119224B1 (ro) | 1993-11-19 | 2004-06-30 | Janssenápharmaceuticaán.V. | Compoziţie farmaceutică pentru tratamentul unor afecţiuni psihotice şi utilizarea acesteia |
ES2085234B1 (es) * | 1994-02-24 | 1997-01-16 | Vita Invest Sa | Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen. |
TW421649B (en) * | 1995-01-31 | 2001-02-11 | Janssen Pharmaceutica Nv | 4-(1H-indol-1yl)-1-piperidinyl derivatives |
US5753664A (en) * | 1995-03-16 | 1998-05-19 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use |
EP1560814A1 (fr) * | 2002-11-13 | 2005-08-10 | Synthon B.V. | Procede de fabrication de la risperidone et des intermediaires associes |
WO2004094414A1 (fr) * | 2003-04-22 | 2004-11-04 | Synthon B.V. | Sels hydrosolubles de risperidone |
EP3106166B1 (fr) * | 2008-02-29 | 2020-12-02 | VM Therapeutics LLC | Composes pour le traitement du syndrome de la douleur et autres troubles |
SG10201609188WA (en) | 2012-02-10 | 2016-12-29 | Ptc Therapeutics Inc | Compounds for treating spinal muscular atrophy |
JP6092264B2 (ja) | 2012-03-01 | 2017-03-08 | ピーティーシー セラピューティクス, インコーポレイテッド | 脊髄性筋委縮症を処置するための化合物 |
MX358514B (es) | 2012-03-23 | 2018-08-24 | Ptc Therapeutics Inc | Compuestos para tratar la atrofia muscular espinal. |
EP2970188A4 (fr) * | 2013-03-15 | 2016-10-19 | Vm Therapeutics Llc | Nouvelles formes cristallines |
WO2015105657A1 (fr) | 2013-12-19 | 2015-07-16 | Ptc Therapeutics, Inc. | Procédés pour moduler la quantité de transcrits d'arn |
US10668171B2 (en) | 2015-05-30 | 2020-06-02 | Ptc Therapeutics, Inc. | Methods for modulating RNA splicing |
IL281633B (en) | 2015-12-10 | 2022-07-01 | Ptc Therapeutics Inc | Methods for treating Huntington's disease |
US11702646B2 (en) | 2016-11-28 | 2023-07-18 | Ptc Therapeutics, Inc. | Methods for modulating RNA splicing |
SG11201911615WA (en) | 2017-06-05 | 2020-01-30 | Ptc Therapeutics Inc | Compounds for treating huntington's disease |
US11608501B2 (en) | 2017-06-14 | 2023-03-21 | Ptc Therapeutics, Inc. | Methods for modifying RNA splicing |
US11395822B2 (en) | 2017-06-28 | 2022-07-26 | Ptc Therapeutics, Inc. | Methods for treating Huntington's disease |
US11382918B2 (en) | 2017-06-28 | 2022-07-12 | Ptc Therapeutics, Inc. | Methods for treating Huntington's Disease |
BR112020019373A2 (pt) | 2018-03-27 | 2020-12-29 | Ptc Therapeutics, Inc. | Compostos para o tratamento da doença de hutington |
EA202092896A1 (ru) | 2018-06-27 | 2021-04-13 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Гетероциклические и гетероарильные соединения для лечения болезни гентингтона |
WO2020005882A1 (fr) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Composés hétéroaryles pour le traitement de la maladie de huntington |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3412094A (en) * | 1967-06-21 | 1968-11-19 | Searle & Co | 5-alkyl-2-amino-4-azido-6-phenylpyrimidines and congeners |
US3960863A (en) * | 1974-06-25 | 1976-06-01 | Sankyo Company Limited | Pyrido[1,2-a]pyrimidinone derivatives |
JPS5146497A (en) * | 1974-10-19 | 1976-04-20 | Masato Aiura | Hobuban |
JPS525795A (en) * | 1975-06-28 | 1977-01-17 | Sankyo Co Ltd | Preparation of tetrahydro pyridopyrimidinone derivatives |
HU173438B (hu) * | 1975-11-27 | 1979-05-28 | Chinoin Gyogyszer Es Vegyeszet | Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom |
-
1980
- 1980-09-29 US US06/191,632 patent/US4342870A/en not_active Expired - Lifetime
-
1981
- 1981-03-03 GR GR64291A patent/GR72488B/el unknown
- 1981-03-04 CA CA000372258A patent/CA1163994A/fr not_active Expired
- 1981-03-17 NZ NZ196522A patent/NZ196522A/en unknown
- 1981-03-17 AU AU68429/81A patent/AU537700B2/en not_active Ceased
- 1981-03-21 MA MA19313A patent/MA19107A1/fr unknown
- 1981-03-24 CS CS812134A patent/CS256366B2/cs unknown
- 1981-03-24 SU SU813261927A patent/SU1068037A3/ru active
- 1981-03-26 PT PT72740A patent/PT72740B/pt not_active IP Right Cessation
- 1981-03-26 DK DK138281A patent/DK159390C/da not_active IP Right Cessation
- 1981-03-26 IL IL62494A patent/IL62494A/xx unknown
- 1981-03-26 PH PH25429A patent/PH16530A/en unknown
- 1981-03-27 YU YU810/81A patent/YU43010B/xx unknown
- 1981-03-27 NO NO811058A patent/NO156752C/no unknown
- 1981-03-27 DE DE8181301335T patent/DE3168433D1/de not_active Expired
- 1981-03-27 ES ES500814A patent/ES500814A0/es active Granted
- 1981-03-27 HU HU81783A patent/HU187329B/hu not_active IP Right Cessation
- 1981-03-27 EP EP81301335A patent/EP0037265B1/fr not_active Expired
- 1981-03-27 IE IE706/81A patent/IE51319B1/en not_active IP Right Cessation
- 1981-03-27 BG BG8151433A patent/BG36199A3/xx unknown
- 1981-03-27 FI FI810956A patent/FI71737C/fi not_active IP Right Cessation
- 1981-03-28 RO RO81103848A patent/RO82508A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
HU187329B (en) | 1985-12-28 |
NZ196522A (en) | 1985-10-11 |
DE3168433D1 (de) | 1985-03-07 |
PT72740B (en) | 1982-11-16 |
DK159390C (da) | 1991-03-04 |
IE51319B1 (en) | 1986-12-10 |
DK159390B (da) | 1990-10-08 |
YU43010B (en) | 1989-02-28 |
AU537700B2 (en) | 1984-07-05 |
PT72740A (en) | 1981-04-01 |
FI71737C (fi) | 1987-02-09 |
FI810956L (fi) | 1981-09-29 |
YU81081A (en) | 1983-12-31 |
BG36199A3 (en) | 1984-09-14 |
IE810706L (en) | 1981-09-28 |
IL62494A0 (en) | 1981-05-20 |
EP0037265A1 (fr) | 1981-10-07 |
GR72488B (fr) | 1983-11-14 |
CA1163994A (fr) | 1984-03-20 |
ES8300763A1 (es) | 1982-11-01 |
IL62494A (en) | 1984-08-31 |
FI71737B (fi) | 1986-10-31 |
AU6842981A (en) | 1981-10-01 |
NO156752B (no) | 1987-08-10 |
NO811058L (no) | 1981-09-29 |
ES500814A0 (es) | 1982-11-01 |
SU1068037A3 (ru) | 1984-01-15 |
NO156752C (no) | 1987-11-18 |
RO82508A (fr) | 1983-09-26 |
DK138281A (da) | 1981-09-29 |
US4342870A (en) | 1982-08-03 |
PH16530A (en) | 1983-11-10 |
EP0037265B1 (fr) | 1985-01-23 |
MA19107A1 (fr) | 1981-10-01 |
RO82508B (ro) | 1983-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS256366B2 (en) | Method of new 3-(1-piperidinylalkyl)-4h-pyridol(1,2-pyrimidine-4-on derivatives production | |
EP0196132B1 (fr) | Dérivés de 1,2-benzisoxazol-3-yle et 1,2-benzisothiazol-3-yle | |
EP0070053B1 (fr) | Dérivés bicycliques de pyrimidin-5-one | |
EP0110435B1 (fr) | ((Bis(aryl)méthylène)-1-pipéridinyl)alcoyl-pyrimidinones | |
US4581171A (en) | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders | |
DK173674B1 (da) | Anti-allergiske præparater indeholdende N-heterocyclyl-4-piperidinaminer, N-heterocyclyl-4-piperidinaminer til brug som antiallergikum og hidtil ukendte N-heterocyclyl-4-piperidinaminer samt fremgangsmåde til fremstilling deraf | |
EP0453042B1 (fr) | 4H-pyrido-(1,2-a)pyrimidin-4-ones substituées sur les positiones 2 et 9 | |
EP0184258B1 (fr) | Dérivés de pipéridinylalkylquinazolines hydroxy ou amino-substituées | |
EP0037713A1 (fr) | Dérivés de 1,3-dihydro-1-((1-pipéridinyl)alkyl)-2H-benzimidazol-2-one | |
JPH0215550B2 (fr) | ||
US4665075A (en) | Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines | |
CZ297220B6 (cs) | Tetrahydro gama -karbolin, zpusob jeho prípravy apouzití, farmaceutická kompozice s jeho obsahem azpusob její prípravy | |
JP3980054B2 (ja) | 抗精神病性の4−(1h−インドリル−1−イル)−1−置換ピペリジン誘導体 | |
US4548939A (en) | 1H-Indol-3-yl containing 1,3-dimethyl-1H-purine-2,6-diones | |
US4533665A (en) | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones | |
HU195793B (en) | Process for the production of new derivatives of 1,2-benziazol -3-il and medical compositions containing thereof as active substance | |
JPH0433797B2 (fr) | ||
JPH0480913B2 (fr) | ||
CZ280767B6 (cs) | 1,2-benzisoxazol-3-ylové a 1,2-benzisothiazol-3-ylové deriváty, způsob jejich výroby a farmaceutické přípravky na jejich bázi |